VISKOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Viskase Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$4.05−0.09 (-2.27%)
Close on Oct 19, 2026
- Market cap
- $58.04M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
$0.00
Consecutive increases
0 years
Not raised last year
Dividend yield
0.00%
Latest annual dividend ÷ share price
Payout ratio, FY2025
-37.4%
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | $0.00 | – | $1.28M | -37.4% |
| FY2024 | – | – | $1.28M | 163.9% |
| FY2023 | – | – | $1.28M | 92.9% |
| FY2022 | – | – | – | – |
| FY2021 | – | – | $0 | 0.0% |
| FY2020 | – | – | $0 | 0.0% |
| FY2019 | – | – | $7.96M | -813.0% |
| FY2018 | – | – | $0 | 0.0% |
| FY2017 | – | – | $6.63M | 121.8% |
| FY2016 | $2.17 | -82.4% | $6.63M | -589.0% |
| FY2015 | $12.32 | – | $37.56M | 173.6% |
| FY2014 | $0.00 | -100.0% | $4.42M | 15.3% |
| FY2013 | $29.73 | +2.5% | $89.81M | 494.8% |
| FY2012 | $29.00 | – | $87.35M | -3138.6% |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.